Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Effects of Psychosocial Skills Training on Self-Stigma and Forgiveness Among Caregivers of Individuals With Psychotic Disorders (RUTBE)

14. november 2026 oppdatert av: Ömer USLU

The Effects of Psychosocial Skills Training on Self-Stigma and Forgiveness Among Caregivers of Individuals With Chronic Mental Illness: A Randomized Controlled Trial

This randomized controlled trial aims to evaluate the effects of psychosocial skills training on self-stigma and forgiveness among family caregivers of individuals with psychotic disorders. Caring for a person with a long-term mental illness can create emotional and social challenges. Family caregivers may experience stigma, difficulties in social relationships, and challenges related to forgiveness.

The study will include 34 adult caregivers who will be randomly assigned to an intervention group (n=17) or a control group (n=17). The intervention group will receive an eight-session, face-to-face psychosocial skills training program delivered once a week. The program will focus on understanding mental illness, improving communication and problem-solving skills, supporting treatment, managing persistent symptoms, coping with stress, and strengthening social functioning. The control group will not receive the training during the study period.

Self-stigma and forgiveness will be assessed in both groups before the intervention, immediately after the eight-session program, and three months after the intervention. The findings will help determine whether psychosocial skills training can reduce self-stigma and improve forgiveness among caregivers of individuals with psychotic disorders.

Studieoversikt

Status

Har ikke rekruttert ennå

Forhold

Intervensjon / Behandling

Detaljert beskrivelse

This study is designed as a two-arm, parallel-group randomized controlled trial to investigate the effects of psychosocial skills training on self-stigma and forgiveness among caregivers of individuals diagnosed with psychotic disorders. The study will be conducted at the Community Mental Health Center affiliated with Söke Fehime Faik Kocagöz State Hospital in Aydın, Türkiye.

A total of 34 caregivers will be recruited and randomly allocated to an intervention group (n=17) or a control group (n=17) using randomizer.org. Eligible participants will be adults aged 18 years or older who are literate and provide care to an individual diagnosed with a psychotic or schizophrenia spectrum disorder according to DSM-5 criteria. Caregivers whose conditions substantially interfere with effective communication will not be eligible. Participation will be voluntary, and informed consent will be obtained before data collection.

The intervention group will participate in a structured psychosocial skills training program based on the principles of Liberman's Social and Independent Living Skills Program and the training manual developed by Yıldız. The program will consist of eight weekly, face-to-face group sessions lasting approximately 90-120 minutes each. The sessions will address group preparation and communication, understanding mental illness and daily living skills, cognitive and perceptual disturbances, treatment and medication management, coping with persistent symptoms and early warning signs, avoiding harmful or ineffective treatments, stress management and self-confidence, and social functioning. Interactive discussions, practical exercises, and homework assignments will be used to support learning and application of skills. Homework reminders may be provided by telephone calls or messages.

The control group will not receive the structured psychosocial skills training during the intervention and follow-up periods. Following completion of the three-month follow-up assessment, the training will also be offered to the control group.

Data will be collected at three time points: baseline, immediately after completion of the eight-session intervention, and three months after the intervention. The Self-Stigma Scale-Family Form will be used to assess caregivers' self-stigma, and the Forgiveness Scale will be used to assess forgiveness. A personal information form will be administered at baseline to collect sociodemographic characteristics.

The study will compare changes in self-stigma and forgiveness scores between the intervention and control groups over time. The findings are expected to provide evidence regarding the potential benefits of structured psychosocial skills training for caregivers of individuals with psychotic disorders.

Studietype

Intervensjonell

Registrering (Antatt)

34

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

    • SÖKE
      • Aydin, SÖKE, Tyrkia (Türkiye), 09200
        • Söke Fehime Faik Kocagöz State Hospital - Community Mental Health Center

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Being 18 years of age or older.
  • Being a family caregiver of an individual diagnosed with a psychotic or schizophrenia spectrum disorder.
  • Being able to read and write.
  • Being willing to participate in the study and providing informed consent.

Exclusion Criteria:

  • Having a condition that prevents effective communication or participation in the study procedures.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Støttende omsorg
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Experimental Group

Participants in this group will receive an eight-session, face-to-face psychosocial skills training program delivered once weekly. Each session will last approximately 90-120 minutes.

The intervention consists of eight weekly, face-to-face psychosocial skills training sessions for family caregivers of individuals with psychotic disorders. Each session will last approximately 90-120 minutes. The program focuses on mental illness awareness, communication, problem-solving, treatment support, symptom management, stress management, and social functioning.

Ingen inngripen: Control Group

Participants in this group will not receive the structured psychosocial skills training program during the intervention and follow-up periods. The training will be offered after completion of the three-month follow-up assessment.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in Caregiver Self-Stigma
Tidsramme: Baseline, immediately after the 8-week intervention, and 3 months after the intervention

Caregiver self-stigma will be assessed using the Self-Stigma Scale-Family Form, a 14-item instrument rated on a five-point Likert scale. Changes in self-stigma scores will be compared between the intervention and control groups across three assessment points.

Baseline, immediately after the 8-week intervention, and 3 months after the intervention
Change in Caregiver Forgiveness
Tidsramme: Baseline, immediately after the 8-week intervention, and 3 months after the intervention

Forgiveness will be assessed using the Forgiveness Scale, a 13-item instrument rated on a seven-point Likert scale. Changes in forgiveness scores will be compared between the intervention and control groups across three assessment points.

Baseline, immediately after the 8-week intervention, and 3 months after the intervention

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Etterforskere

  • Hovedetterforsker: Hava Salık, PhD, Hakkari University

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

1. desember 2026

Primær fullføring (Antatt)

31. mai 2027

Studiet fullført (Antatt)

31. mai 2027

Datoer for studieregistrering

Først innsendt

14. november 2026

Først innsendt som oppfylte QC-kriteriene

14. november 2026

Først lagt ut (Faktiske)

19. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

19. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

14. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • RUTBE-RCT-2026

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

IPD-planbeskrivelse

Individual participant data will not be shared with other researchers due to the sensitive nature of the psychosocial information collected from family caregivers of individuals with psychotic disorders and the need to protect participant confidentiality and privacy. Study findings will be reported in aggregate form without identifying individual participants.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .